Literature DB >> 4729897

The renal handling of diphenylhydantoin and 5-(p-hydroxyphenyl)-5-phenylhydantoin.

F Bochner, W D Hooper, J M Sutherland, M J Eadie, J H Tyrer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4729897     DOI: 10.1002/cpt1973145791

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  8 in total

1.  Interaction between vigabatrin and phenytoin.

Authors:  E M Rimmer; A Richens
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 2.  Pharmacokinetic evaluation of hemodialysis in acute drug overdose.

Authors:  S Takki; J G Gambertoglio; D H Honda; T N Tozer
Journal:  J Pharmacokinet Biopharm       Date:  1978-10

3.  Laboratory control of anticonvulsant dosage.

Authors:  M J Eadie
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 4.  Clinical toxicology.

Authors:  J A Vale
Journal:  Postgrad Med J       Date:  1993-01       Impact factor: 2.401

5.  Rate of phenytoin accumulation in man: a simulation study.

Authors:  T M Ludden; J P Allen; L W Schneider; S A Stavchansky
Journal:  J Pharmacokinet Biopharm       Date:  1978-10

Review 6.  Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.

Authors:  E Yukawa
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of phenytoin.

Authors:  A Richens
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

Review 8.  Formation of active metabolites of anticonvulsant drugs. A review of their pharmacokinetic and therapeutic significance.

Authors:  M J Eadie
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.